Tech limitations promote tumor growth perception

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 9
Volume 32
Issue 9

Technological limitations, not biology, could be the cause of perceived high rates of breast tumor growth in younger women.

Technological limitations, not biology, could be the cause of perceived high rates of breast tumor growth in younger women. Previously, poor mammography screening outcomes for women aged 40 to 49 were pinned on faster tumor growth and reduced tumor detectability, but a new study shows the latter is the major culprit.

A breast cancer screening computer simulation model was developed for the study to estimate how biology and technology affect mammography sensitivity. The researchers calibrated the predicted breast cancer incidence rates to the actual rates from the Surveillance, Epidemiology, and End Results database. They compared distributions of screen-detected tumor sizes to the actual distributions obtained from the Breast Cancer Surveillance Consortium to estimate relative impact of lower tumor detectability and tumor volume doubling time on the younger women's screening outcomes.

The lowered ability to detect tumors accounted for 79% of the poorer sensitivity in the model, according to the research, which was published in the Journal of the National Cancer Institute. The remaining 21% was due to faster tumor growth (doi:10.1093/jnci/djq271).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.